Home ➤ Life Science ➤ Pharmaceuticals ➤ Nuclear Medicine Market
Nuclear Medicine Market
Published date: Aug 2025 • Formats:
Request Sample Schedule a Call

Nuclear Medicine Market By Product Type (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application(Cardiology, Oncology, Neurology, Thyroid, Lymphoma, Bone Metastasis, Urology, Pulmonary Scans, Endocrine Tumor, Other), By End-user(Hospitals, Diagnostic Centers, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Aug 2025
  • Report ID: 21148
  • Number of Pages: 309
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Nuclear Medicine Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Nuclear Medicine Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Nuclear Medicine Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Nuclear Medicine Market Attractiveness Analysis, By Product Type
        • 3.3.1. Diagnostics
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
            • 3.3.1.2.1. SPECT
              • 3.3.1.2.1.1. TL-201
              • 3.3.1.2.1.2. TC-99m
              • 3.3.1.2.1.3. I-123
              • 3.3.1.2.1.4. GA-67
              • 3.3.1.2.1.5. Others
            • 3.3.1.2.2. PET
              • 3.3.1.2.2.1. SR-82/RB-82
              • 3.3.1.2.2.2. PYLARIFY
              • 3.3.1.2.2.3. Illuccix
              • 3.3.1.2.2.4. F-18
              • 3.3.1.2.2.5. Others
        • 3.3.2. Therapeutics
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
            • 3.3.2.2.1. Alpha Emitters
              • 3.3.2.2.1.1. RA-223
              • 3.3.2.2.1.2. Others
            • 3.3.2.2.2. Beta Emitters
              • 3.3.2.2.2.1. Y-90
              • 3.3.2.2.2.2. SM-153
              • 3.3.2.2.2.3. Re-186
              • 3.3.2.2.2.4. Lu-177
              • 3.3.2.2.2.5. I-131
              • 3.3.2.2.2.6. Others
            • 3.3.2.2.3. Brachytherapy
              • 3.3.2.2.3.1. Palladium-103
              • 3.3.2.2.3.2. Iridium-192
              • 3.3.2.2.3.3. Iodine-125
              • 3.3.2.2.3.4. Cesium-131
              • 3.3.2.2.3.5. Others
      • 3.4. Global Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.5. Global Nuclear Medicine Market Attractiveness Analysis, By Application
        • 3.5.1. Urology
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Oncology
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Cardiology
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
            • 3.5.3.2.1. SPECT
            • 3.5.3.2.2. PET
            • 3.5.3.2.3. Therapeutic Applications
        • 3.5.4. Neurology
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Thyroid
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
            • 3.5.5.2.1. SPECT
            • 3.5.5.2.2. Therapeutic Applications
        • 3.5.6. Lymphoma
          • 3.5.6.1. Insights
          • 3.5.6.2. Key Takeaways
        • 3.5.7. Bone Metastasis
          • 3.5.7.1. Insights
          • 3.5.7.2. Key Takeaways
            • 3.5.7.2.1. SPECT
            • 3.5.7.2.2. Therapeutic Applications
        • 3.5.8. Pulmonary Scans
          • 3.5.8.1. Insights
          • 3.5.8.2. Key Takeaways
        • 3.5.9. Endocrine Tumor
          • 3.5.9.1. Insights
          • 3.5.9.2. Key Takeaways
        • 3.5.10. Others
          • 3.5.10.1. Insights
          • 3.5.10.2. Key Takeaways
      • 3.6. Global Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.7. Global Nuclear Medicine Market Attractiveness Analysis, By End-user
        • 3.7.1. Hospitals
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Diagnostic Centers
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Others
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
    • 4. Global Nuclear Medicine Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Nuclear Medicine Market Attractiveness Analysis, By Region
    • 5. North America Nuclear Medicine Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • 5.4. North America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.5. North America Nuclear Medicine Market Attractiveness Analysis, By Application
      • 5.6. North America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.7. North America Nuclear Medicine Market Attractiveness Analysis, By End-user
      • 5.8. North America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Nuclear Medicine Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Nuclear Medicine Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.5. Europe Nuclear Medicine Market Attractiveness Analysis, By Application
      • 6.6. Europe Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.7. Europe Nuclear Medicine Market Attractiveness Analysis, By End-user
      • 6.8. Europe Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Nuclear Medicine Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Nuclear Medicine Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.5. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By Application
      • 7.6. Asia Pacific Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.7. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By End-user
      • 7.8. Asia Pacific Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Nuclear Medicine Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.5. Latin America Nuclear Medicine Market Attractiveness Analysis, By Application
      • 8.6. Latin America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.7. Latin America Nuclear Medicine Market Attractiveness Analysis, By End-user
      • 8.8. Latin America Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Nuclear Medicine Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Nuclear Medicine Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.5. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By Application
      • 9.6. Middle East & Africa Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.7. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By End-user
      • 9.8. Middle East & Africa Nuclear Medicine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. The institute for radioelements
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. The Australian Nuclear Science and Technology Organization
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. NTP Radioisotopes SOC Ltd
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Nordion (Canada), Inc
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Mallinckrodt
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Lantheus Medical Imaging, Inc
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Jubilant Life Sciences Ltd
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. GE Healthcare
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Eczacıbaşı-Monrol
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Eckert & Ziegler
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. Cardinal Health
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. Bracco Imaging S.P.A
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 2. Global Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 3. Global Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 4. Global Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 5. Global Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 6. Global Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 7. Global Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 8. Global Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 9. Global Nuclear Medicine Market Value (US$ Mn), By Region, 2020-2034
      • Table 10. North America Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 11. North America Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 12. North America Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 13. North America Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 14. North America Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 15. North America Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 16. North America Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 17. North America Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 18. North America Nuclear Medicine Market Value (US$ Mn), By Country, 2020–2034
      • Table 19. The US Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 20. The US Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 21. The US Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 22. The US Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 23. The US Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 24. The US Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 25. The US Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 26. The US Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 27. Canada Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 28. Canada Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 29. Canada Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 30. Canada Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 31. Canada Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 32. Canada Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 33. Canada Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 34. Canada Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 35. Europe Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 36. Europe Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 37. Europe Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 38. Europe Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 39. Europe Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 40. Europe Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 41. Europe Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 42. Europe Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 43. Europe Nuclear Medicine Market Value (US$ Mn), By Country, 2020–2034
      • Table 44. Germany Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 45. Germany Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 46. Germany Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 47. Germany Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 48. Germany Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 49. Germany Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 50. Germany Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 51. Germany Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 52. France Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 53. France Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 54. France Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 55. France Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 56. France Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 57. France Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 58. France Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 59. France Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 60. UK Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 61. UK Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 62. UK Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 63. UK Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 64. UK Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 65. UK Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 66. UK Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 67. UK Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 68. Spain Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 69. Spain Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 70. Spain Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 71. Spain Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 72. Spain Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 73. Spain Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 74. Spain Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 75. Spain Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 76. Italy Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 77. Italy Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 78. Italy Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 79. Italy Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 80. Italy Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 81. Italy Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 82. Italy Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 83. Italy Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 84. Russia Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 85. Russia Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 86. Russia Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 87. Russia Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 88. Russia Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 89. Russia Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 90. Russia Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 91. Russia Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 92. Netherlands Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 93. Netherlands Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 94. Netherlands Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 95. Netherlands Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 96. Netherlands Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 97. Netherlands Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 98. Netherlands Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 99. Netherlands Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 100. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 101. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 102. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 103. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 104. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 105. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 106. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 107. Rest of Europe Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 108. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 109. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 110. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 111. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 112. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 113. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 114. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 115. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 116. Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Country, 2020–2034
      • Table 117. China Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 118. China Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 119. China Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 120. China Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 121. China Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 122. China Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 123. China Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 124. China Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 125. Japan Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 126. Japan Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 127. Japan Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 128. Japan Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 129. Japan Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 130. Japan Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 131. Japan Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 132. Japan Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 133. South Korea Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 134. South Korea Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 135. South Korea Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 136. South Korea Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 137. South Korea Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 138. South Korea Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 139. South Korea Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 140. South Korea Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 141. India Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 142. India Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 143. India Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 144. India Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 145. India Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 146. India Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 147. India Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 148. India Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 149. Australia Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 150. Australia Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 151. Australia Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 152. Australia Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 153. Australia Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 154. Australia Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 155. Australia Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 156. Australia Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 157. New Zealand Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 158. New Zealand Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 159. New Zealand Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 160. New Zealand Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 161. New Zealand Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 162. New Zealand Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 163. New Zealand Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 164. New Zealand Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 165. Singapore Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 166. Singapore Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 167. Singapore Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 168. Singapore Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 169. Singapore Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 170. Singapore Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 171. Singapore Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 172. Singapore Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 173. Thailand Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 174. Thailand Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 175. Thailand Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 176. Thailand Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 177. Thailand Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 178. Thailand Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 179. Thailand Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 180. Thailand Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 181. Vietnam Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 182. Vietnam Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 183. Vietnam Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 184. Vietnam Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 185. Vietnam Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 186. Vietnam Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 187. Vietnam Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 188. Vietnam Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 189. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 190. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 191. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 192. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 193. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 194. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 195. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 196. Rest of Asia Pacific Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 197. Latin America Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 198. Latin America Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 199. Latin America Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 200. Latin America Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 201. Latin America Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 202. Latin America Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 203. Latin America Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 204. Latin America Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 205. Latin America Nuclear Medicine Market Value (US$ Mn), By Country, 2020–2034
      • Table 206. Brazil Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 207. Brazil Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 208. Brazil Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 209. Brazil Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 210. Brazil Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 211. Brazil Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 212. Brazil Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 213. Brazil Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 214. Mexico Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 215. Mexico Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 216. Mexico Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 217. Mexico Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 218. Mexico Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 219. Mexico Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 220. Mexico Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 221. Mexico Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 222. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 223. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 224. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 225. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 226. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 227. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 228. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 229. Rest of Latin America Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 230. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 231. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 232. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 233. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 234. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 235. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 236. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 237. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 238. Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Country, 2020–2034
      • Table 239. South Africa Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 240. South Africa Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 241. South Africa Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 242. South Africa Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 243. South Africa Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 244. South Africa Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 245. South Africa Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 246. South Africa Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 247. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 248. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 249. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 250. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 251. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 252. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 253. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 254. Saudi Arabia Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 255. UAE Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 256. UAE Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 257. UAE Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 258. UAE Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 259. UAE Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 260. UAE Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 261. UAE Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 262. UAE Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
      • Table 263. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 264. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Diagnostics, 2020–2034
      • Table 265. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Therapeutics, 2020–2034
      • Table 266. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Application, 2020–2034
      • Table 267. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Cardiology, 2020–2034
      • Table 268. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Thyroid, 2020–2034
      • Table 269. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By Bone Metastasis, 2020–2034
      • Table 270. Rest of Middle East & Africa Nuclear Medicine Market Value (US$ Mn), By End-user, 2020–2034
    • List of Figures
      • Figure 1. Global Nuclear Medicine Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Nuclear Medicine Market
      • Figure 5. Global Nuclear Medicine Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Nuclear Medicine Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 8. Global Nuclear Medicine Market Attractiveness Analysis, By Application
      • Figure 9. Global Nuclear Medicine Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 10. Global Nuclear Medicine Market Attractiveness Analysis, By End-user
      • Figure 11. Global Nuclear Medicine Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Nuclear Medicine Market Attractiveness Analysis, By Region
      • Figure 13. North America Nuclear Medicine Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 14. North America Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • Figure 15. North America Nuclear Medicine Market (US$ Mn), by Diagnostics, 2020-2034
      • Figure 16. North America Nuclear Medicine Market (US$ Mn), by Therapeutics, 2020-2034
      • Figure 17. North America Nuclear Medicine Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 18. North America Nuclear Medicine Market Attractiveness Analysis, By Application
      • Figure 19. North America Nuclear Medicine Market (US$ Mn), by Urology, 2020-2034
      • Figure 20. North America Nuclear Medicine Market (US$ Mn), by Oncology, 2020-2034
      • Figure 21. North America Nuclear Medicine Market (US$ Mn), by Cardiology, 2020-2034
      • Figure 22. North America Nuclear Medicine Market (US$ Mn), by Neurology, 2020-2034
      • Figure 23. North America Nuclear Medicine Market (US$ Mn), by Thyroid, 2020-2034
      • Figure 24. North America Nuclear Medicine Market (US$ Mn), by Lymphoma, 2020-2034
      • Figure 25. North America Nuclear Medicine Market (US$ Mn), by Bone Metastasis, 2020-2034
      • Figure 26. North America Nuclear Medicine Market (US$ Mn), by Pulmonary Scans, 2020-2034
      • Figure 27. North America Nuclear Medicine Market (US$ Mn), by Endocrine Tumor, 2020-2034
      • Figure 28. North America Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 29. North America Nuclear Medicine Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 30. North America Nuclear Medicine Market Attractiveness Analysis, By End-user
      • Figure 31. North America Nuclear Medicine Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 32. North America Nuclear Medicine Market (US$ Mn), by Diagnostic Centers, 2020-2034
      • Figure 33. North America Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 34. North America Nuclear Medicine Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 35. North America Nuclear Medicine Market Attractiveness Analysis, By Country
      • Figure 36. Europe Nuclear Medicine Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 37. Europe Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • Figure 38. Europe Nuclear Medicine Market (US$ Mn), by Diagnostics, 2020-2034
      • Figure 39. Europe Nuclear Medicine Market (US$ Mn), by Therapeutics, 2020-2034
      • Figure 40. Europe Nuclear Medicine Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 41. Europe Nuclear Medicine Market Attractiveness Analysis, By Application
      • Figure 42. Europe Nuclear Medicine Market (US$ Mn), by Urology, 2020-2034
      • Figure 43. Europe Nuclear Medicine Market (US$ Mn), by Oncology, 2020-2034
      • Figure 44. Europe Nuclear Medicine Market (US$ Mn), by Cardiology, 2020-2034
      • Figure 45. Europe Nuclear Medicine Market (US$ Mn), by Neurology, 2020-2034
      • Figure 46. Europe Nuclear Medicine Market (US$ Mn), by Thyroid, 2020-2034
      • Figure 47. Europe Nuclear Medicine Market (US$ Mn), by Lymphoma, 2020-2034
      • Figure 48. Europe Nuclear Medicine Market (US$ Mn), by Bone Metastasis, 2020-2034
      • Figure 49. Europe Nuclear Medicine Market (US$ Mn), by Pulmonary Scans, 2020-2034
      • Figure 50. Europe Nuclear Medicine Market (US$ Mn), by Endocrine Tumor, 2020-2034
      • Figure 51. Europe Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 52. Europe Nuclear Medicine Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 53. Europe Nuclear Medicine Market Attractiveness Analysis, By End-user
      • Figure 54. Europe Nuclear Medicine Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 55. Europe Nuclear Medicine Market (US$ Mn), by Diagnostic Centers, 2020-2034
      • Figure 56. Europe Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 57. Europe Nuclear Medicine Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 58. Europe Nuclear Medicine Market Attractiveness Analysis, By Country
      • Figure 59. Asia Pacific Nuclear Medicine Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 60. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • Figure 61. Asia Pacific Nuclear Medicine Market (US$ Mn), by Diagnostics, 2020-2034
      • Figure 62. Asia Pacific Nuclear Medicine Market (US$ Mn), by Therapeutics, 2020-2034
      • Figure 63. Asia Pacific Nuclear Medicine Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 64. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By Application
      • Figure 65. Asia Pacific Nuclear Medicine Market (US$ Mn), by Urology, 2020-2034
      • Figure 66. Asia Pacific Nuclear Medicine Market (US$ Mn), by Oncology, 2020-2034
      • Figure 67. Asia Pacific Nuclear Medicine Market (US$ Mn), by Cardiology, 2020-2034
      • Figure 68. Asia Pacific Nuclear Medicine Market (US$ Mn), by Neurology, 2020-2034
      • Figure 69. Asia Pacific Nuclear Medicine Market (US$ Mn), by Thyroid, 2020-2034
      • Figure 70. Asia Pacific Nuclear Medicine Market (US$ Mn), by Lymphoma, 2020-2034
      • Figure 71. Asia Pacific Nuclear Medicine Market (US$ Mn), by Bone Metastasis, 2020-2034
      • Figure 72. Asia Pacific Nuclear Medicine Market (US$ Mn), by Pulmonary Scans, 2020-2034
      • Figure 73. Asia Pacific Nuclear Medicine Market (US$ Mn), by Endocrine Tumor, 2020-2034
      • Figure 74. Asia Pacific Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 75. Asia Pacific Nuclear Medicine Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 76. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By End-user
      • Figure 77. Asia Pacific Nuclear Medicine Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 78. Asia Pacific Nuclear Medicine Market (US$ Mn), by Diagnostic Centers, 2020-2034
      • Figure 79. Asia Pacific Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 80. Asia Pacific Nuclear Medicine Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 81. Asia Pacific Nuclear Medicine Market Attractiveness Analysis, By Country
      • Figure 82. Latin America Nuclear Medicine Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 83. Latin America Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • Figure 84. Latin America Nuclear Medicine Market (US$ Mn), by Diagnostics, 2020-2034
      • Figure 85. Latin America Nuclear Medicine Market (US$ Mn), by Therapeutics, 2020-2034
      • Figure 86. Latin America Nuclear Medicine Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 87. Latin America Nuclear Medicine Market Attractiveness Analysis, By Application
      • Figure 88. Latin America Nuclear Medicine Market (US$ Mn), by Urology, 2020-2034
      • Figure 89. Latin America Nuclear Medicine Market (US$ Mn), by Oncology, 2020-2034
      • Figure 90. Latin America Nuclear Medicine Market (US$ Mn), by Cardiology, 2020-2034
      • Figure 91. Latin America Nuclear Medicine Market (US$ Mn), by Neurology, 2020-2034
      • Figure 92. Latin America Nuclear Medicine Market (US$ Mn), by Thyroid, 2020-2034
      • Figure 93. Latin America Nuclear Medicine Market (US$ Mn), by Lymphoma, 2020-2034
      • Figure 94. Latin America Nuclear Medicine Market (US$ Mn), by Bone Metastasis, 2020-2034
      • Figure 95. Latin America Nuclear Medicine Market (US$ Mn), by Pulmonary Scans, 2020-2034
      • Figure 96. Latin America Nuclear Medicine Market (US$ Mn), by Endocrine Tumor, 2020-2034
      • Figure 97. Latin America Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 98. Latin America Nuclear Medicine Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 99. Latin America Nuclear Medicine Market Attractiveness Analysis, By End-user
      • Figure 100. Latin America Nuclear Medicine Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 101. Latin America Nuclear Medicine Market (US$ Mn), by Diagnostic Centers, 2020-2034
      • Figure 102. Latin America Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 103. Latin America Nuclear Medicine Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 104. Latin America Nuclear Medicine Market Attractiveness Analysis, By Country
      • Figure 105. Middle East & Africa Nuclear Medicine Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 106. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By Product Type
      • Figure 107. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Diagnostics, 2020-2034
      • Figure 108. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Therapeutics, 2020-2034
      • Figure 109. Middle East & Africa Nuclear Medicine Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 110. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By Application
      • Figure 111. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Urology, 2020-2034
      • Figure 112. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Oncology, 2020-2034
      • Figure 113. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Cardiology, 2020-2034
      • Figure 114. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Neurology, 2020-2034
      • Figure 115. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Thyroid, 2020-2034
      • Figure 116. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Lymphoma, 2020-2034
      • Figure 117. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Bone Metastasis, 2020-2034
      • Figure 118. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Pulmonary Scans, 2020-2034
      • Figure 119. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Endocrine Tumor, 2020-2034
      • Figure 120. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 121. Middle East & Africa Nuclear Medicine Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 122. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By End-user
      • Figure 123. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 124. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Diagnostic Centers, 2020-2034
      • Figure 125. Middle East & Africa Nuclear Medicine Market (US$ Mn), by Others, 2020-2034
      • Figure 126. Middle East & Africa Nuclear Medicine Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 127. Middle East & Africa Nuclear Medicine Market Attractiveness Analysis, By Country
    • The institute for radioelements
    • The Australian Nuclear Science and Technology Organization
    • NTP Radioisotopes SOC Ltd
    • Nordion (Canada), Inc
    • Mallinckrodt
    • Lantheus Medical Imaging, Inc
    • Jubilant Life Sciences Ltd
    • GE Healthcare
    • Eczacıbaşı-Monrol
    • Eckert & Ziegler
    • Cardinal Health
    • Bracco Imaging S.P.A

Related Reports

Our Clients

  • Our Clients
Nuclear Medicine Market
  • 21148
  • Aug 2025
    • ★★★★★
      ★★★★★
    • (118)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options